My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Fasturtec



Sanofi Winthrop IndustrieEU/1/00/170/001-002

Main Information

Trade NameFasturtec
Active SubstancesRasburicase
Dosage FormPowder and solvent for concentrate for solution for infusion
Licence HolderSanofi Winthrop Industrie
Licence NumberEU/1/00/170/001-002

Group Information

ATC CodeV03AF Detoxifying agents for antineoplastic treatment
V03AF07 rasburicase

Status

License statusAuthorised
Licence Issued23/02/2001
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back
Follow medicine

Print